Design and development of metoprolol succinate sustained release tablet using Eulophia herbacae and Remusatia vivipara tuber mucilage as novel drug release modifiers
Source abstract
Abstract
The present research was aimed to develop Metoprolol succinate sustained-release tablet by wet granulation using novel polymersEulophia herbacae and Remusatia vivipara tuber mucilage as release retardants. The formulations were prepared using a 32 full factorial design. In the current research, two factors were tested each at three levels. The concentration of Eulophia herbacea mucilage (X1) and Remusatia vivipara mucilage (X2) were selected as independent variables, and swelling index, t75 of % cumulative drug release, and drug content were selected as dependent variables. The prepared tablets were evaluated by weight variation test, hardness, friability, swelling index, drug release, and drug content. The optimized tablet was compared with reference formulation PROLOMET XL 100. The drug release kinetics study was performed by various models. It reveals that formulation follows anomalous diffusion (non-fickian) pattern and follows both diffusion-controlled and swelling controlled mechanisms of drug release.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Analytical Methods in Pharmaceuticals
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of PharmacologyPharmacy, School of Pharmaceutical Sciences, SADTM Campus, Jaipur National University, Jaipur, Rajasthan, India
Department of Pharmacognosy, Shastry Institute of Pharmacy, Erandol, Jalgaon, Maharashtra, India
References (32)
Show source-provided references
1. 10.1016/S1461-5347(00)00247-910.1016/S1461-5347(00)00247-9 ↗
2. Jaimini M · J Drug DelivTher · 2012 · 2 · 142
3. 10.1097/00005344-200302000-0000110.1097/00005344-200302000-00001 ↗
4. Tripathi KD · Jaypee Publication · 2005 · 6 · 528
5. 10.1155/2013/71673610.1155/2013/716736 ↗
6. 10.1016/0378-5173(95)04355-110.1016/0378-5173(95)04355-1 ↗
7. 10.1016/S2222-1808(12)60123-610.1016/S2222-1808(12)60123-6 ↗
8. 10.4103/0250-474X.5818910.4103/0250-474X.58189 ↗
9. Algieri C · Mater Technol · 2020 · 1
10. 10.1016/S0378-8741(97)00150-510.1016/S0378-8741(97)00150-5 ↗
11. Bhurat MR · Research J. Pharm Tech · 2013 · 6 · 366
12. Shelke SP · Int JPharmTech Res · 2011 · 3 · 1649
13. Bhurat MR · JPharm Res · 2012 · 5 · 321
14. Jadhav RP · Melet. Int J Res BiosciAgric Technol · 2017 · 5 · 293
15. Kokate CK. Practical Pharmacognosy.Vallabh Publication, New Delhi. 3rd Ed.1991:107-109.
16. Indian Pharmacopoeia · 1985
17. Naskar S · J Drug Deliv Sci Technol · 2019 · 53 · 1
18. 10.1080/10667857.2018.147514210.1080/10667857.2018.1475142 ↗
19. Shirsath NR · Mater Technol · 2020 · 1
20. 10.1016/j.jsps.2019.04.01210.1016/j.jsps.2019.04.012 ↗
21. Shinde SC · Int J Pharm Sci Res · 2015 · 6 · 1075
22. Gunda RK · Mintage J Pharm Med Sci · 2018 · 7 · 22
23. Kassaye L · Afr Health Sci · 2013 · 13 · 369
24. Yadav G · Middle-East J Sci Res · 2013 · 16 · 782
25. 10.3329/dujps.v16i1.3338110.3329/dujps.v16i1.33381 ↗
26. 10.4103/0250-474X.5818910.4103/0250-474X.58189 ↗
27. 10.1080/10667857.2019.163901910.1080/10667857.2019.1639019 ↗
28. 10.4103/2394-2002.14888110.4103/2394-2002.148881 ↗
29. Abdul H, Suresh C, et al. Formulation and evaluation of once-daily sustained release aceclofenac prosophis juliflora gum matrix tablets. International Journal of Pharmaceutical Sciences Review and Research. 2010; 1(2): 23–28.
30. Vinod R · Asian Journal of Biomedical and Pharmaceutical Sciences · 2013 · 3 · 38
31. 10.1016/j.jsps.2015.03.00510.1016/j.jsps.2015.03.005 ↗
32. 10.1016/j.jsps.2016.10.00610.1016/j.jsps.2016.10.006 ↗